companydata.dkcompanydata.dk

NORDIC BIOTECH K/S: Financial statements 2024

CVR: 26290724

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000. The solvency ratio was 99.9%.

Gross Profit
DKK -157,000
Profit/Loss
DKK 101,458,000
Equity
DKK 127,032,000
Total Assets
DKK 127,129,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--157K101.5M127M-
2023--133K1.3M32.2M-
2022---44.6M34.2M0
2021---6.4M78.7M0
2020---1.4M85.1M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

NORDIC BIOTECH K/S: The 2023 annual report is outJun 13, 2024

NORDIC BIOTECH K/S has published its annual report for 2023. Gross profit came to DKK -133,000, and the net result was DKK 1,254,000.

About NORDIC BIOTECH K/S

NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.

Source: annual report 2024, Danish Business Authority